TrialThe Journal of antimicrobial chemotherapy2018

Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs.

Maria C Puertas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.